Evidence map›Paper›PMID 41117671›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Infection Control in Carceral Facilities.

Amadin A Olotu, Joseph A Bick, B Sue Medley-Lane, Anne C Spaulding

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Amadin A OlotuRollins School of Public Health, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-4832-0391
Joseph A BickCalifornia Department of Corrections and Rehabilitation, California Correctional Health Care Services, Davis, California, USA.ORCID 0009-0005-1535-3970
B Sue Medley-LaneInfection Prevention and Control, Centurion Health, Sterling, Virginia, USA.
Anne C SpauldingRollins School of Public Health, Emory University, Atlanta, Georgia, USA.

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
Binx Health Inc.CDC HHSEmory UniversityGates FoundationHRSA, and Health Through WallsInfectious Disease Society of AmericaJames Ferguson RISE NU50CD300866Medical Association of GeorgiaNIAID NIH HHS P30 AI168386NIH
6 · The paper itself

Abstract

At the end of 2022, 5.4 million people (1 of every 48 adults) were either in jail, in prison, or on probation/parole in the United States. One in 20 persons in the United States (5%) will be incarcerated during their lifetime. Among those newly admitted to carceral settings, the prevalence of active tuberculosis disease and infections from blood-borne viruses and sexually transmitted pathogens is substantially higher than in community counterparts. Exposure to the carceral setting places residents, employees, and visitors at risk for acquiring communicable diseases, predominately those transmitted via airborne routes. Efforts to prevent, mitigate, or control infectious diseases benefit those within carceral facilities and also surrounding communities. This review briefly explores some of the changes, challenges, and opportunities relevant to the prevention and control of infectious diseases in jails, prisons, and juvenile residential facilities. It also emphasizes the need for adequate education and training when planning and implementing interventions.

Indexed as

Communicable DiseasesInfection ControlPrisonsAdultHumansJailsUnited Statescarceralcorrectionalinfection prevention and controljailprison

Identifiers

PMID41117671
PMCPMC13131935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.